Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-307.72%Earnings Yield
VS
Market
Sector
Industry
History
$ 1.01Close
$ 0.53 - $ 4.4 52-Week Range
Ticker Information
Ticker
STROCompany Name
SUTRO BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSUTRO BIOPHARMA INC - Earnings Yield Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
STRO - Earnings Yield Historical data
| Date | Earnings Yield | Market Capitalization | Net Income Common Stock |
|---|---|---|---|
| 6/30/2025 | -307.72% | $ 67.82M | $ -208.7M |
| 3/31/2025 | -303.06% | $ 80.91M | $ -245.22M |
| 12/31/2024 | -217.21% | $ 104.72M | $ -227.46M |
| 9/30/2024 | -37.96% | $ 326.54M | $ -123.95M |
| 6/30/2024 | -47.15% | $ 263.92M | $ -124.45M |
| 3/31/2024 | -33.23% | $ 345.99M | $ -114.96M |
| 12/31/2023 | -52.3% | $ 204.19M | $ -106.79M |
| 9/30/2023 | -136.68% | $ 126.17M | $ -172.45M |
| 6/30/2023 | -54.31% | $ 262.69M | $ -142.66M |
| 3/31/2023 | -36.63% | $ 355.25M | $ -130.14M |
Key Performance Insights, Last 5 Years
- SUTRO BIOPHARMA INC's latest trailing twelve months (TTM) Earnings Yield stands at 2.27%.
- Over the past 5 years, SUTRO BIOPHARMA INC's average Earnings Yield has been -72.17%.
- The median Earnings Yield for SUTRO BIOPHARMA INC during this period was -39.75%
- SUTRO BIOPHARMA INC reached its highest Earnings Yield over the past 5 years at 2.27%.
- The lowest Earnings Yield recorded by SUTRO BIOPHARMA INC in the same timeframe -307.72%
SUTRO BIOPHARMA INC's Earnings Yield vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Earnings Yield Benchmarks
Similar metrics to Net Inc. Cmn.:
- Price to Earnings - [Calculation] Measures a company’s [MarketCap] in relation to its Net Income [NetIncCmn]. A high P/E ratio indicates that investors anticipate greater future earnings growth compared to companies with a lower P/E.
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
Definition of Earnings Yield
[Calculation] The Earnings Yield, also known as the inverse of the PE ratio [PE], expresses a company’s earnings [NetIncCmn] as a percentage of [MarketCap].Net Inc. Cmn. / Market Cap
(=) Earnings Yield Earnings Yield for SUTRO BIOPHARMA INC is calculated as follows: Net Inc. Cmn. [ $ 12.63M ] / Market Cap [ $ 556.29M ]
(=) Earnings Yield [ 2.27% ] STRO - Earnings Yield, Last 5 years
-307.72%
Minimum
Jun 30, 2025
2.27%
Maximum
Sep 30, 2020
-72.17%
Average
-39.75%
Median
Earnings Yield Benchmark AnalysisMarket
The chart above depicts the distribution of Earnings Yield for companies in the Total Stock Market. The average Earnings Yield of the companies is 0.33% with a standard deviation of 9.82%.
The following table provides additional summary stats:
Earnings Yield in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | -31.79% |
| max | 32.87% |
| average | 0.33% |
| median | 2.78% |
| std | 9.82% |